View Alert


Originator: DHSC & NHS England and Improvement: Supply disruption alert

Issue date: 04-Jan-2021 08:42:21

This alert has been issued to:
  • Care Trusts
  • Mental Health Trusts
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Other contacts
  • Specialists Trusts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • NHS Regional Offices
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Special Health Authorities
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • Mental Health & Learning Disabilities
  • Acute Trusts
  • Community Trusts
  • GP - Locum
  • NHS 111 and Out of hours providers
  • GP Practices
  • DHSC Supply Disruption - Medicines
  • Community Pharmacy
  • Primary Care Networks
  • GP Practices 1

Action category: Action

Title: Lithium carbonate (Priadel) 200mg and 400mg tablets - Supply Disruption Update

Broadcast content:

This alert contains up to date information following an agreement on price between the Department of Health and Social Care and Essential Pharma and supersedes SDA/2020/012(U) issued on 08 October 2020.

The attached alert contains further information.

Please note that no response is required via the CAS website to this alert.



Additional information: NHS England and NHS Improvement Regional Offices: please cascade this alert to community pharmacy.

Alert reference: SDA/2020/012(U2)

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency